Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Practice Point
Nature Reviews Nephrology 1, 12–13 (1 November 2005) | doi:10.1038/ncpneph0022
Is the efficacy of epoetin beta in anemic peritoneal dialysis patients maintained with fortnightly doses?
Abstract
Grzeszczak W et al. (2005) The efficacy and safety of once-weekly and once-fortnightly subcutaneous epoetin β in peritoneal dialysis patients with chronic renal anaemia. Nephrol Dial Transplant 20: 936–944 Synopsis Background Subcutaneous epoetin beta is a convenient and effective treatment for anemia in peritoneal dialysis patients.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
